publication date: Apr. 14, 2017

Pelotonia funds 11 additional Ohio State cancer research projects

Eleven cancer research ideas have received funding from Pelotonia, the annual cycling event that has raised more than $130 million for cancer research at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

The 2017 Pelotonia Idea Grants Program projects range from understanding the protective effects of female hormones against melanoma and helping breast cancer patients navigate treatment choices to identifying new genes linked to prostate cancer and understanding the role of specific genetic mutations in an aggressive form of leukemia.

In the past seven years, more than 100 OSUCCC – James research teams have received Pelotonia Idea Grants, which provide funding support for two years. Projects are selected through a peer-review process conducted by both internal and external scientists not competing for grants in the current funding year.

A total of $1.08 million will be awarded in the latest round of Pelotonia Idea Grants, with $10 million in funding awarded since the program’s inception. This represents the work of investigators across eight colleges plus Nationwide Children’s Hospital as well as Cincinnati Children’s Hospital and The Ohio State University Wexner Medical Center.

Pelotonia 17 will take place Aug. 4 to 6. For more information or to register, visit

“It is an honor for our community of riders and donors to be able to invest in brilliant ideas that advance cancer research and ultimately save lives for those affected by a disease that has touched so many of us personally,” said Doug Ulman, president and CEO of Pelotonia. “We are excited to continue working with our growing Pelotonia movement toward our shared … Continue reading Pelotonia funds 11 additional Ohio State cancer research projects

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.